Form 4: Alignment Healthcare President Dawn Maroney Sells 30,000 Shares

Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock at an average price of $15.9896 on March 17, 2025, while also receiving 170,968 shares on March 13, 2025.

Summary

• Dawn Christine Maroney, President of Alignment Healthcare, filed a Form 4 detailing changes in beneficial ownership.
• On March 13, 2025, Maroney acquired 170,968 shares of common stock.
• These shares include restricted stock units, shares in lieu of cash settlement for an incentive award, and shares granted as a discretionary award.
• On March 17, 2025, Maroney sold 30,000 shares of common stock at an average price of $15.9896.
• The sales were executed under a Rule 10b5-1 trading plan adopted on March 13, 2024.
• Following these transactions, Maroney directly owns 2,417,700 shares of Alignment Healthcare.
• The price per share for the sale ranged from $15.53 to $16.20.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While there's a sale of shares by an executive, it's under a pre-arranged plan and the executive still holds a significant stake. The acquisition of shares through vesting and awards is a positive sign.

Positives

• The acquisition of shares reflects additional compensation and incentives for the reporting person.
• The reporting person still holds a significant number of shares after the sale, indicating continued alignment with the company's success.

Negatives

• The sale of shares by a company president could be interpreted negatively by some investors, although it was conducted under a pre-arranged trading plan.

Risks

• Executive stock sales can sometimes create uncertainty among investors, even when conducted under a 10b5-1 plan.
• Market reaction to the sale could put downward pressure on the stock price in the short term.

Industry Context

Executive stock transactions are common and closely monitored in the healthcare industry, as they can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without raising concerns about insider trading.

Comparison to Industry Standards

• Executive compensation packages in the healthcare industry often include stock options and restricted stock units to align management's interests with those of shareholders.
• Sales under 10b5-1 plans are a common practice among executives at publicly traded companies, including those in the healthcare sector, such as UnitedHealth Group (UNH) and CVS Health (CVS).
• The size of the transaction is relatively small compared to the overall market capitalization of Alignment Healthcare and the total holdings of the reporting person.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholder sentiment in the short term.
• The continued holding of a large number of shares by the president suggests ongoing commitment to the company's success.

Key Dates